Robitussin and Delsym Cough Medications Recalled for Storage Temperature Violations
Family Dollar Stores is recalling Robitussin Cough N Chest Congestion (4 FL OZ, SKU 919471) and Delsym Orange (3 FL OZ, SKU 901880) because these medications were stored outside proper temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a CGMP deviation related to improper storage temperature, which may affect product quality but poses no direct or reported safety threat.
Plain-English summary
Family Dollar Stores, LLC is recalling Robitussin Cough N Chest Congestion 4 FL OZ (SKU 919471) and Delsym Orange 3 FL OZ (SKU 901880) that were distributed to specific Family Dollar Store locations between April 30, 2022 and June 10, 2022.
The medications were held outside appropriate storage temperature conditions, which violates Current Good Manufacturing Practice (CGMP) standards. Improper storage may affect the quality and stability of these over-the-counter cough medications.
Consumers who purchased these specific products during the identified timeframe should discard them. If you have questions about whether your medication is affected or have concerns about its use, contact your healthcare provider or pharmacist.
The recalled product
- Product
- ROBITUSSIN COUGH N CHEST CONGESTION 4 FL OZ SKU 919471 DELSYM ORANGE 3 FL OZ SKU 901880 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Cough and Cold Medication
- Hazard
- improper-storage
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 919471
- 901880
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27